Selling Buzz: HCA Healthcare Inc. [HCA] SVP & Chief Ethics Officer Whalen Kathleen M sells 1,734 shares of the company


Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. HCA Healthcare Inc. shares valued at $457,097 were sold by Whalen Kathleen M on Feb 17. At $263.61 per share, Whalen Kathleen M sold 1,734 shares. The insider’s holdings dropped to 9,962 shares worth approximately $2.43 million following the completion of this transaction.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Also, Berres Jennifer sold 4,000 shares, netting a total of over 1,020,912 in proceeds. Following the sale of shares at $255.23 each, the insider now holds 7,392 shares.

Before that, RUTHERFORD BILL B had sold 30,000 shares from its account. In a trade valued at $7,745,568, the CFO and EVP traded HCA Healthcare Inc. shares for $258.19 each. Upon closing the transaction, the insider’s holdings decreased to 30,000 shares, worth approximately $19.94 million.

As published in a research note from BMO Capital Markets on July 06, 2022, HCA Healthcare Inc. [HCA] has been rated down from a Market perform to an Underperform and the price target has been revised to $160 from $233. This represents a -52.69% premium over Wednesday’s closing price. Analysts at Loop Capital started covering the stock with ‘”a Buy”‘ outlook in a report released in mid June. As of May 27, 2022, Bernstein has increased its “Mkt perform” rating to a “an Outperform” for HCA. Earlier on March 29, 2022, Wells Fargo initiated its rating. Their recommendation was “an Equal weight” for HCA stock.

Analyzing HCA Stock Performance

On Wednesday, HCA Healthcare Inc. [NYSE: HCA] rose 0.35% to $244.30. The stock’s lowest price that day was $240.00, but it reached a high of $245.19 in the same session. During the last five days, there has been a drop of approximately -3.86%. Over the course of the year, HCA Healthcare Inc. shares have jumped approximately 1.81%. Shares of the company reached a 52-week high of $269.09 on 01/23/23 and a 52-week low of $239.43 on 01/03/23. A 50-day SMA is recorded $251.79, while a 200-day SMA reached $217.52. Nevertheless, trading volume fell to 0.92 million shares from 1.27 million shares the previous day.

Support And Resistance Levels for HCA Healthcare Inc. (HCA)

According to the 24-hour chart, there is a support level at 241.14, which, if violated, would cause prices to drop to 237.97. In the upper region, resistance lies at 246.33. The next price resistance is at 248.35. RSI (Relative Strength Index) is 35.90 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -9.31, which suggests the price will decrease in the coming days. Percent R is at 82.16%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Is HCA Healthcare Inc. subject to short interest?

Stocks of HCA Healthcare Inc. saw a sharp steep in short interest on Jan 12, 2023 dropping by -0.76 million shares to 2.92 million. Data from Yahoo Finance shows that the short interest on Dec 14, 2022 was 3.68 million shares. A decline of -26.03% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.78 of the overall float, the days-to-cover ratio (short ratio) decline to 2.78.

Which companies own the most shares of HCA Healthcare Inc. (HCA)?

According to The Vanguard Group, Inc. filings, the company currently owns 17,042,919 shares, which is about 6.03% of the total HCA shares outstanding. The investor’s shares have plunged by -143,343 from its previous 13-F filing of 17186262.0 shares. With the completion of the buy transaction, Wellington Management Co. LLP’s stake is now worth $3,665,189,849. Sanders Capital LLC reduced a -3.46% interest valued at $2.74 billion while BlackRock Fund Advisors sold a -335,283 stake. A total of -56,956 shares of HCA Healthcare Inc. were sold by SSgA Funds Management, Inc. during the quarter, and 1,734,194 were bought by T. Rowe Price Associates, Inc. In its current portfolio, Harris Associates LP holds 6,670,965 shares valued at $1.7 billion.

In terms of HCA Healthcare Inc. share price expectations, FactSet research, analysts set an average price target of $282.41 in the next 12 months, up nearly 16.66% from the previous closing price of $243.45. Analysts anticipate HCA Healthcare Inc. stock to reach $310.00 by 2023, with the lowest price target being $243.00. In spite of this, 25 analysts ranked HCA Healthcare Inc. stock as an Overweight at the end of 2023. On January 10, 2022, Citigroup assigned a price target of “a Buy” to the stock and resumed coverage with a $306.


Please enter your comment!
Please enter your name here